STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Movano Inc SEC Filings

MOVE Nasdaq

Welcome to our dedicated page for Movano SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking the path from prototype to FDA clearance can feel overwhelming when Movano Inc.’s disclosures stretch over hundreds of pages of technical jargon. Whether you’re watching the Evie Ring’s clinical milestones or simply need R&D burn-rate figures, Stock Titan’s AI turns dense paragraphs into clear takeaways, making Movano Inc. SEC filings explained simply a reality.

Need the details fast? Our dashboard streams every document the moment it lands on EDGAR—from a Movano Inc. quarterly earnings report 10-Q filing that breaks down sensor R&D costs, to an Movano Inc. 8-K material events explained summary covering fresh trial data. Curious about leadership confidence? We surface Movano Inc. insider trading Form 4 transactions and send real-time alerts for each Movano Inc. Form 4 insider transactions real-time update. Want the big picture without wading through footnotes? Click the AI summary beside any Movano Inc. annual report 10-K simplified or drill into the Movano Inc. proxy statement executive compensation tables in seconds.

Professionals use these insights to:

  • Compare cash runway across quarters with Movano Inc. earnings report filing analysis
  • Monitor FDA-related milestones disclosed in 8-Ks
  • Spot patterns in Movano Inc. executive stock transactions Form 4 ahead of clinical announcements
With AI-powered summaries, expert context, and comprehensive, real-time coverage of every form type, understanding Movano Inc. SEC documents with AI becomes the fastest way to make informed decisions.

Rhea-AI Summary

Movano Inc. (MOVE) called a special stockholder meeting to vote on four items affecting capital access and equity plans. Proposal 1 seeks approval to issue shares under a committed equity facility with Chardan (the “ChEF”) beyond Nasdaq’s 19.99% cap. The facility permits sales of common stock to Chardan for up to $1,000,000,000 in aggregate purchase price, subject to limits, including a 4.99% beneficial ownership cap. The company states the current Exchange Cap would otherwise restrict issuance to 166,887 shares at prices below $5.30 (“Nasdaq Minimum Price”).

Proposal 2 would amend the certificate of incorporation to increase authorized common stock from 500,000,000 to 2,500,000,000 shares (with total authorized capital adjusted accordingly). The Board cites flexibility for financings, acquisitions, compensation and other corporate purposes.

Proposal 3 would amend the 2019 Incentive Plan to add 500,000 shares, supporting previously granted, discounted options issued in lieu of cash compensation and one-time awards, all contingent on approval. Examples include contingent options at $1.25 expiring December 31, 2025. Proposal 4 authorizes adjournment of the meeting if needed. Common shares outstanding were 834,857 as of November 10, 2025; Series A Preferred were 3,000 shares, then convertible into 87,694 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Movano Inc. (MOVE) reported an insider equity change. On 11/03/2025, a director forfeited 12,442 previously awarded RSUs in lieu of directors’ fees and received a stock option for 55,250 shares at an exercise price of $1.25.

The option will become exercisable upon shareholder approval of an amendment increasing shares under the Omnibus Incentive Plan. Following the transactions, the director beneficially owned 2,690 common shares. The disclosed option lists an expiration date of 12/31/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
-
Rhea-AI Summary

Movano Inc. (MOVE) director Form 4: On 11/03/2025, a director forfeited 8,295 restricted stock units in lieu of directors’ fees and received a stock option grant covering 21,500 shares of Common Stock at an exercise price of $1.25 per share. The option is contingent on shareholder approval of an amendment to the Omnibus Incentive Plan and will become exercisable upon that approval. The option shows an expiration date of 12/31/2025 and was reported as directly owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
Rhea-AI Summary

Movano Inc. (MOVE) reported an insider equity change. On 11/03/2025, a director forfeited 6,841 restricted stock units in lieu of directors’ fees and received a grant of stock options for 10,000 shares at an exercise price of $1.25.

The options will become exercisable upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the shares authorized for issuance. Following the transactions, non-derivative common stock beneficially owned was 0 shares, and derivative holdings were 10,000 options, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
-
Rhea-AI Summary

Movano Inc. (MOVE) reported an insider equity adjustment by its Chief Executive Officer and Director. On 11/03/2025, the officer forfeited 39,226 RSUs in lieu of salary and received a grant of 77,834 stock options with an exercise price of $1.25. The filing states these options were granted contingent upon shareholder approval of an amendment increasing shares under the Omnibus Incentive Plan, and will become exercisable upon that approval. Following the transactions, the officer reported 1,944 shares beneficially owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
-
Rhea-AI Summary

Movano Inc. (MOVE) reported an insider transaction on a Form 4. A director and Chief Technology Officer forfeited previously awarded RSUs in lieu of salary and received a stock option grant. On 11/03/2025, the insider disposed of 21,260 shares at a reported price of $0. Following the transaction, the insider directly owned 356 shares of common stock.

Concurrently, the insider was granted 42,250 stock options with an exercise price of $1.25 per share. The grant is contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan, and the option will become exercisable upon that approval. The option carries an expiration date of 12/31/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
Rhea-AI Summary

Movano Inc. (MOVE) disclosed a Form 4 for its CFO, reporting a compensation adjustment on 11/03/2025. The executive forfeited 31,871 restricted stock units at a $0 price in lieu of salary and received a grant of stock options for 84,834 shares with a $1.25 exercise price.

The option becomes exercisable only upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases shares authorized for issuance. The option carries an expiration date of 12/31/2025. Following the transaction, the executive beneficially owned 5,204 shares of common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
-
Rhea-AI Summary

Movano (MOVE) reported an insider compensation change. On 11/03/2025, a director forfeited 13,271 RSUs previously awarded under the Omnibus Incentive Plan, in lieu of directors’ fees, and received a grant of stock options for 35,500 shares at an exercise price of $1.25.

The option award was contingent upon shareholder approval of an amendment to increase shares authorized under the plan; the options will become exercisable upon that approval. After the transaction, the director beneficially owned 1,874 shares of common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
insider
-
Rhea-AI Summary

Movano Inc. agreed to merge with Corvex, Inc., with Corvex becoming a wholly owned subsidiary. Based on an exchange ratio reflecting a $250.0 million valuation for Corvex and $10.0 million for Movano, pre‑merger Corvex holders would own about 96.2% of the combined company and Movano holders about 3.8%, subject to adjustments for concurrent financings and liabilities. An earnout grants additional shares if the volume‑weighted average price exceeds $15.00 and $25.00 per share for 20 of 30 trading days within specified post‑closing periods.

Movano completed a $3.0 million Series A preferred round (convertible at $5.50 per share, capped by a 19.99% beneficial ownership limit) and entered a Chardan committed equity facility of up to $1.0 billion, each subject to stated conditions. Corvex completed a $37.1 million private placement. Closing requires shareholder approvals, S‑4 effectiveness, and Nasdaq listing approval. A loan amendment extends maturity to March 31, 2026, adding a $3.0 million repayment premium upon asset sale before closing and providing for IP transfer to the lender if obligations remain unsatisfied at closing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
merger
Filing
Rhea-AI Summary

Movano Inc. agreed to merge with Corvex, Inc., making Corvex a wholly owned subsidiary and effectively shifting control to Corvex stockholders. Based on the merger’s exchange formula and stated valuations, pre‑merger Corvex holders would own approximately 96.2% of the combined company and pre‑merger Movano holders about 3.8% on a fully diluted basis, before adjustments for related financings. The agreement includes earnouts tied to volume‑weighted average price milestones of $15.00 (within five years) and $25.00 (within seven years).

Movano raised $3.0 million via Series A Preferred Stock and entered a $1.0 billion committed equity facility with Chardan (subject to Nasdaq’s exchange cap, ownership limits, and an effective resale registration). Corvex completed $37.1 million in concurrent private financing. Closing requires stockholder approvals, SEC effectiveness of an S‑4, and Nasdaq listing approval. Support agreements cover 21.2% of Movano shares and certain holders agreed to a 180‑day lock‑up after closing. Movano also extended a loan’s maturity to March 31, 2026; if legacy assets are sold pre‑closing, repayment includes $1.5 million principal plus other obligations and a $3.0 million premium, and if unpaid at closing, Movano’s pre‑closing IP and related assets transfer to the lender.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
149.69%
Tags
current report

FAQ

What is the current stock price of Movano (MOVE)?

The current stock price of Movano (MOVE) is $10.973 as of November 18, 2025.

What is the market cap of Movano (MOVE)?

The market cap of Movano (MOVE) is approximately 8.5M.
Movano Inc

Nasdaq:MOVE

MOVE Rankings

MOVE Stock Data

8.47M
720.49k
24.94%
15.13%
13.54%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLEASANTON